1. Postoperative stereotactic radiosurgery for intracranial solitary fibrous tumors: systematic review and pooled quantitative analysis

   • Danielle Golub
   • Joshua D. McBriar
   • Amir R. Dehdashti

   Review 13 November 2023 Pages: 229 - 239

   

2. Particle beam radiotherapy in the treatment of WHO grade 2 and 3 meningiomas: an early experience from Shanghai Proton and Heavy Ion Center

   • Xianxin Qiu
   • Jing Gao
   • Lin Kong

   Research 17 November 2023 Pages: 241 - 250

   

3. Qualitative MR features to identify non-enhancing tumors within glioblastoma’s T2-FLAIR hyperintense lesions

   • Shota Yamamoto
   • Yoshiko Okita
   • Haruhiko Kishima

   Research 02 November 2023 Pages: 251 - 259

   

4. Impact of boost sequence in concurrent chemo-radiotherapy on newly diagnosed IDH-wildtype glioblastoma multiforme

   • Nalee Kim
   • Joongyo Lee
   • Hong In Yoon

   Research 20 October 2023 Pages: 261 - 268

   

5. Correction to: Impact of boost sequence in concurrent chemo-radiotherapy on newly diagnosed IDH-wildtype glioblastoma multiforme

   • Nalee Kim
   • Joongyo Lee
   • Hong In Yoon

   Correction 08 November 2023 Pages: 269 - 269

6. Safety of microneurosurgical interventions for superficial and deep-seated brain metastases: single-center cohort study of 637 consecutive cases

   • Stefanos Voglis
   • Luis Padevit
   • Carlo Serra

   Research Open access 10 November 2023 Pages: 271 - 278

   

7. Capturing evolving definitions of 12 select rare CNS tumors: a timely report from CBTRUS and NCI-CONNECT

   • Mackenzie Price
   • Corey Neff
   • Quinn T. Ostrom

   Research 19 November 2023 Pages: 279 - 290

   

8. Incidence, management, and outcome of incidental meningioma: what has happened in 10 years?

   • Olivia Näslund
   • Per Sveino Strand
   • Asgeir S. Jakola

   Research Open access 08 November 2023 Pages: 291 - 299

   

9. Effects of intrathecal pemetrexed on the survival of patients with leptomeningeal metastasis from lung adenocarcinoma: a propensity score matching analysis

   • Yaping Hong
   • Qian Miao
   • Gen Lin

   Research 23 November 2023 Pages: 301 - 312

   

10. Enhanced sensitivity of electrocorticography during awake craniotomy using a novel circular grid electrode

    • Brin E. Freund
    • Anteneh M. Feyissa
    • William O. Tatum

    Research 07 November 2023 Pages: 313 - 320

    

11. Is reduced-dose whole-brain radiotherapy also feasible in primary CNS lymphoma for curative or salvage purpose?

    • Min-Kyun Ko
    • Yoo-Kang Kwak
    • Jin-Ho Song

    Research 14 November 2023 Pages: 321 - 328

    

12. The long non-coding RNA OTX2-AS1 promotes tumor growth and predicts response to BCL-2 inhibition in medulloblastoma

    • Nan Qin
    • Eunice Paisana
    • Marc Remke

    Research Open access 17 November 2023 Pages: 329 - 342

    

13. Treatment and survival of patients with small cell lung cancer and brain metastasis

    • Chi-Lu Chiang
    • Huai-Che Yang
    • Yuh-Min Chen

    Research 20 November 2023 Pages: 343 - 351

    

14. Clinical outcomes of stereotactic biopsy on children with pontine diffuse midline glioma

    • A. Basit Khan
    • Huy Q. Dang
    • Guillermo Aldave

    Case Study 09 November 2023 Pages: 353 - 360

    

15. Predictors for delayed awakening in adult glioma patients receiving awake craniotomy under monitored anesthesia care

    • Huan-Tang Lin
    • Chun-Ming Lin
    • Ko-Ting Chen

    Case Study Open access 02 November 2023 Pages: 361 - 372

    

16. The outcome of central nervous system hemangioblastomas in Von Hippel-Lindau (VHL) disease treated with belzutifan: a single-institution retrospective experience

    • Aroosa Zamarud
    • Neelan J. Marianayagam
    • Steven D. Chang

    Case Study 13 November 2023 Pages: 373 - 379

    

17. Stereotactic radiosurgery for large vestibular schwannomas: 2.5 cm and beyond

    • Jason Sheehan
    • Isaac Yang
    • Daniel M. Prevedello

    Correspondence 17 November 2023 Pages: 381 - 383

    

18. The ruse of reduction – comment to Zeng et al.

    • Vincent Cassidy
    • Ryan J. Brisson

    Correspondence 17 November 2023 Pages: 385 - 386

19. Correction to: Undetected pseudoprogressions in the CeTeG/NOA-09 trial: hints from postprogression survival and MRI analyses

    • Thomas Zeyen
    • Daniel Paech
    • Christina Schaub

    Correction Open access 03 November 2023 Pages: 387 - 387